Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Panchal

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Chemical Science|January 30, 2026
Search for active and inactive ion insertion sites in organic crystalline materialsHarshan Reddy Gopidi, Alae Eddine Lakraychi, Abhishek A Panchal, et al.
Bioorganic & Medicinal Chemistry Letters|June 16, 2005
(1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: further optimisation as highly potent and selective MSK-1-inhibitorsMark J Bamford, Nicholas Bailey, Susannah Davies, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2009
Orally active C-6 heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]pyridine acid pump antagonists (APAs)Nick Bailey, Mark J Bamford, Delphine Brissy, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2005
(1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: a novel class of potent MSK-1-inhibitorsMark J Bamford, Michael J Alberti, Nicholas Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2013
Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonistsDavid M Wilson, James Apps, Nicholas Bailey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2024
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSAE Felip, B C Cho, V Gutiérrez, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Chemical Science|January 30, 2026
Search for active and inactive ion insertion sites in organic crystalline materialsHarshan Reddy Gopidi, Alae Eddine Lakraychi, Abhishek A Panchal, et al.
Bioorganic & Medicinal Chemistry Letters|June 16, 2005
(1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: further optimisation as highly potent and selective MSK-1-inhibitorsMark J Bamford, Nicholas Bailey, Susannah Davies, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2009
Orally active C-6 heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]pyridine acid pump antagonists (APAs)Nick Bailey, Mark J Bamford, Delphine Brissy, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2005
(1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: a novel class of potent MSK-1-inhibitorsMark J Bamford, Michael J Alberti, Nicholas Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2013
Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonistsDavid M Wilson, James Apps, Nicholas Bailey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2024
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSAE Felip, B C Cho, V Gutiérrez, et al.
Pageof 3